Identifying pancreatic cancer subtypes to improve immunotherapy effectiveness
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
This study is looking at ways to create better immunotherapy treatments for veterans with pancreatic cancer by understanding the different types of tumors they have, so that doctors can provide more personalized care that fits each patient's unique needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michael E Debakey VA Medical Center NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10813019 on NIH RePORTER |
What this research studies
This research focuses on pancreatic ductal adenocarcinoma (PDAC), particularly in veterans, who are at a higher risk for this cancer. The project aims to develop effective immunotherapy treatments by stratifying PDAC patients into distinct subtypes based on their tumor's genetic and epigenetic characteristics. By utilizing advanced genomic sequencing and the Epigenomic Deconvolution method, the research seeks to understand the unique immune environments of these tumors, which could lead to more personalized and effective treatment strategies. The goal is to tailor immunotherapy approaches to the specific needs of each patient based on their tumor subtype.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans diagnosed with pancreatic ductal adenocarcinoma.
Not a fit: Patients with other types of cancer or those not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for pancreatic cancer patients, improving their treatment outcomes.
How similar studies have performed: Other research has shown promise in using genomic and epigenomic approaches to tailor cancer therapies, indicating that this method could be a viable strategy for PDAC as well.
Where this research is happening
Houston, United States
- Michael E Debakey VA Medical Center — Houston, United States (Active)
Researchers
- Principal investigator: Yao, Qizhi C. — Michael E Debakey VA Medical Center
- Study coordinator: Yao, Qizhi C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.